HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toxicological evaluation of saxitoxin, neosaxitoxin, gonyautoxin II, gonyautoxin II plus III and decarbamoylsaxitoxin with the mouse neuroblastoma cell bioassay.

Abstract
Four major paralytic shellfish poisoning (PSP) toxins in pure form-saxitoxin (STX), neosaxitoxin (NEO), gonyautoxin II (GTX II), and decarbamoylsaxitoxin (dcSTX), and mixed gonyautoxin II plus III (GTX II/III)-were toxicologically evaluated in the neuroblastoma cell bioassay and compared with the United States Food and Drug Administration standard reference saxitoxin (FDA STX). Mean relative toxicities of these experimental preparations were 99.5 (STX), 128.0 (NEO), 48.4 (GTX II) and 42.6 (dcSTX) when compared with FDA STX set arbitrarily at 100. Two mixtures of GTX II/III with relative concentrations of 1:2.5 and 4:1 had percentage relative toxicities of 52.4 and 54.5, respectively. Except for GTX II/III, which increased in toxicity, the toxicities of the experimental toxin preparations were not affected by boiling for 5 min in equal volumes of either 0.1 or 1.0 N HCl. Detailed examinations of dose-responses of each individual toxin preparation in the cell bioassay revealed some differences in response profiles. The toxicological data presented here support and extend previous information collected with the mouse bioassay and HPLC. The EC(50) values of STX and GTX II/III obtained under different conditions of matrix (acetic acid nu. ethanol), filtration (filtered 0.22 mum or unfiltered) and time in storage at 5 degrees C after opening of the sealed ampoules were largely unaffected by any of the experimental treatments.
AuthorsJ F Jellett, J E Stewart, M V Laycock
JournalToxicology in vitro : an international journal published in association with BIBRA (Toxicol In Vitro) Vol. 9 Issue 1 Pg. 57-65 (Feb 1995) ISSN: 0887-2333 [Print] England
PMID20650063 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: